In this week’s podcast, Stewart Gandolf talks with Sean Young, former CMO of Penn State Health, about why healthcare marketing remains misunderstood in many organizations—and what marketing leaders can do…
At the Medicarians Conference, Ricardo Carcas, assistant special agent in charge of the Office of Investigations, discussed cases of fraud in the ACA and how the DOJ is combatting it.…
Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pairs two…
This brief describes current coverage of GLP-1s in Medicare and Medicaid, the Centers for Medicare & Medicaid Services’ (CMS) efforts to expand access and lower costs for GLP-1s through temporary…
It would sound like good news that more health citizens, globally, are engaged with more information about health – a health information “abundance,” by the look at the data. But…
At AACR, there was talk of Chinese biotech's place in cancer research, oncology’s comms issue, and more.
Why the AMA Says Mental Health Chatbots Need Crisis Detection What You Should Know The Legislative Push: In letters to the Congressional AI Caucus, the Congressional Digital Health Caucus, and…
The Biopharma Bottleneck: Why Courier Health Raised $50M to Fix Fragmented Patient Journeys What You Should Know The Funding: New York-based Courier Health has closed a $50 million Series B…
AI governance in healthcare has a branding problem. The word “governance” alone is enough to make half the room shut down. I’ve seen it happen. You put that word on…
Everything you need to know about biotech today from The Readout newsletter